Acellular tissue-engineered vessel is approved for use in adults as a vascular conduit for extremity arterial injury ...
The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.
The FDA has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), a new subcutaneous injection formulation of Opdivo.
(HealthDay News) — Surgical residency programs can improve working environments using Lean methodology, according to a study published online in JAMA Surgery.
Dietary acid load has been implicated in chronic kidney disease (CKD), but reducing it can provide kidney protection.
Consuming grape juice 5 times or more per week was associated with 79% reduced odds of erectile dysfunction compared with no ...
Time burdens associated with cancer care extend beyond the burden of time spent accessing care outside the home.
(HealthDay News) — The A (H5N1) virus generally causes mild illness of short duration, mainly among U.S. adults exposed to infected animals, according to a study published online in the New England ...
Pain coping skills training is beneficial for patients undergoing maintenance hemodialysis and experiencing chronic pain.
A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...
Men with negative multiparametric magnetic resonance imaging results avoiding biopsy do not have an increased risk for clinically significant prostate cancer.
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.